Glutathione S-transferase (GST) inhibitors

被引:35
作者
Mathew, N [1 ]
Kalyanasundaram, M [1 ]
Balaraman, K [1 ]
机构
[1] Vector Control Res Ctr, Indian Council Med Res, Pondicherry 605006, India
关键词
anticancer agent; antiparasitic agent; glutathione analogue; GST inhibitor;
D O I
10.1517/13543776.16.4.431
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The glutathione S-transferases (GSTs; EC 2.5.1.18) comprise a family of widely distributed Phase II detoxication enzymes that catalyse the conjugation of a broad variety of reactive electrophiles to the nucleophilic sulfur atom of the major intracellular thiol, the tripeptide glutathione. The diverse functions, including catalytic GSH conjugation, passive ligandin-type binding and modulation of signal transduction, may be selectively targeted by different inhibitors. GST inhibitors are emerging as promising therapeautic agents for managing the development of resistance amongst anticancer agents. In diagnostic medicine, as well as in antiparasitic drug development, GST inhibitors are important lead molecules. In this review, the important molecules known for their GST inhibition together with potential therapeutic uses are summarised.
引用
收藏
页码:431 / 444
页数:14
相关论文
共 111 条
[21]   THE SPONTANEOUS AND GLUTATHIONE S-TRANSFERASE-MEDIATED REACTION OF CHLORAMBUCIL WITH GLUTATHIONE [J].
CIACCIO, PJ ;
TEW, KD ;
LACRETA, FP .
CANCER COMMUNICATIONS, 1990, 2 (08) :279-286
[22]   IDENTIFICATION OF A GLUTATHIONE S-TRANSFERASE ASSOCIATED WITH MICROSOMES OF TUMOR-CELLS RESISTANT TO NITROGEN MUSTARDS [J].
CLAPPER, ML ;
TEW, KD .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (12) :1915-1921
[23]   A role for glutathione transferases functioning as glutathione peroxidases in resistance to multiple herbicides in black-grass [J].
Cummins, I ;
Cole, DJ ;
Edwards, R .
PLANT JOURNAL, 1999, 18 (03) :285-292
[24]   CLINICAL PHARMACOKINETICS OF SULFASALAZINE [J].
DAS, KM ;
DUBIN, R .
CLINICAL PHARMACOKINETICS, 1976, 1 (06) :406-425
[25]  
DIRVEN HAAM, 1995, CANCER RES, V55, P1701
[26]   Induction of apoptosis by curcumin:: mediation by glutathione S-transferase P1-1 inhibition [J].
Duvoix, A ;
Morceau, F ;
Delhalle, S ;
Schmitz, M ;
Schnekenburger, M ;
Galteau, MM ;
Dicato, M ;
Diederich, M .
BIOCHEMICAL PHARMACOLOGY, 2003, 66 (08) :1475-1483
[27]   Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrug [J].
Findlay, VJ ;
Townsend, DM ;
Saavedra, JE ;
Buzard, GS ;
Citro, ML ;
Keefer, LK ;
Ji, XH ;
Tew, KD .
MOLECULAR PHARMACOLOGY, 2004, 65 (05) :1070-1079
[28]   ISOZYME SPECIFICITY OF NOVEL GLUTATHIONE-S-TRANSFERASE INHIBITORS [J].
FLATGAARD, JE ;
BAUER, KE ;
KAUVAR, LM .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 33 (01) :63-70
[29]   X-ray structure of glutathione S-transferase from the malarial parasite Plasmodium falciparum [J].
Fritz-Wolf, K ;
Becker, A ;
Rahlfs, S ;
Harwaldt, P ;
Schirmer, RH ;
Kabsch, W ;
Becker, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (24) :13821-13826
[30]  
GUPTA V, 1995, CANCER CHEMOTH PHARM, V36, P13